Tags:BioTechCareDataHealthTechPlatformProductRecommendationsResearchScienceService
Genetron Holdings Limited (“Genetron Health” or the “Company”) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.
Location: China, Guangdong Province, Beijing
Member count: 1001-5000
Total raised: $71M
Founded date: 2013

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
21.11.2019-$71MVivo Capit...dealstreet...

Mentions in press and media 12

DateTitleDescriptionCategoryAuthorSource
02.09.2022Genetron H...BEIJING, Sept. 02, 2022 (GLOBE...--einpresswi...
10.01.2022Genetron :...Genetron Health Reiterates Ful...--marketscre...
10.01.2022Genetron H...BEIJING, Jan. 10, 2022 (GLOBE ...--marketscre...
30.11.2021Genetron :...Genetron Holdings Limited (Na...--marketscre...
15.11.2021Genetron H...BEIJING, Nov. 15, 2021 (GLOBE ...--marketscre...
28.10.2021Genetron H...Innovative Technology of HCCsc...--marketscre...
28.10.2021Genetron H...BEIJING, Oct. 28, 2021 (GLOBE ...--marketscre...
25.03.2021GENETRON H...Disclaimer The following pres...--marketscre...
24.03.2021Genetron H...BEIJING--(BUSINESS WIRE)--Mar ...--oaoa.com/n...
21.11.2019Chinese ge...Premium Beijing-based Genetro...-Eudora Wan...dealstreet...
Show more